Shares of Aurobindo Pharma Ltd ended at ₹1,220.70, down by ₹1.30, or 0.11%, on the BSE. Previous Post Mastek UK arm wins £49-million 5-year biometrics contract from British Home Office Next Post What’s driving strong flows into gold and silver ETFs despite volatility, explains ICICI Pru AMC's Haria Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email and website in this browser for the next time I comment.Post Comment
